New York State Common Retirement Fund Celldex Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 22,237 shares of CLDX stock, worth $573,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,237
Previous 29,737
25.22%
Holding current value
$573,492
Previous $1.1 Million
31.34%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$238 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$99.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$89.2 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$85.9 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.21B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...